Mathematical models of ovarian cancer incidence

Epidemiology

Volumn 16, Issue 4, 2005, Pages 508-515

  Rosner, Bernard A ^a,b,e   Colditz, Graham A ^a,b,d   Webb, Penny M ^c   Hankinson, Susan E ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d DANA FARBER HARVARD CANCER CENTER   (United States)

^e CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; EXPOSURE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MENOPAUSE; OVARY CANCER; OVULATION; PARITY; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; UTERINE TUBE LIGATION;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INCIDENCE; MENOPAUSE; MIDDLE AGED; MODELS, STATISTICAL; NURSES; OVARIAN NEOPLASMS; PARITY; PREGNANCY; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; STERILIZATION, TUBAL; UNITED STATES;

EID: 20544452047     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000164557.81694.63     Document Type: Article

References (32)

1. Moolgavkar S. Cancer models. Epidemiology 1990;1:419-420.
2. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
3. Constantino J, Gail M, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91:1541-1548.
4. Armitage P, Doll R. The age distribution of cancer and a multistage theory of carcinogenesis. Br J Cancer. 1954;8:1-12.
5. Moolgavkar S, Knudson A Jr. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 1981;66:1037-1052.
6. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol. 1992;136:1184-1203.
7. Pike MC. Age-related factors in cancers of the breast, ovary, and endometrium. J Chronic Dis 1987;40(Suppl 2):59S-69S.
8. Pike MC, Krailo MD, Henderson BE, et al. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature. 1983;303:767-770.
9. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774-1786.
10. Cramer D, Liberman R, Titus-Ernstoff L, et al. Genital talc exposure and risk for ovarian cancer. Int J Cancer. 1999;81:351-356.
11. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst. 1999;91:1459-1467.
12. Colditz GA. The Nurses' Health Study: a cohort of US women followed since 1976. JAMWA 1995;50:40-44, 63.
13. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
14. Rich-Edwards J, Corsano K, Stampfer M. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994; 140:1016-1019.
15. Colditz G, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol. 2000;152:950-964.
16. Colditz G, Rosner B, Chen WY, et al. Risk factors for breast cancer: according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96:218-228.
17. Pike M, Ross R, Spicer D. Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol. 1998;147:718-721.
18. Rockhill B, Colditz G, Rosner B. Bias in breast cancer analyses due to error in age at menopause. Am J Epidemiol. 2000;151:404-408.
19. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet. 1994;344:1250-1254.
20. Purdie D, Green A, Bain C, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer. 1995;62:678-684.
21. Albrektsen G, Heuch I, Kvale G. Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes Control. 1996;7:421-427.
22. Cooper GS, Schildkraut JM, Whittemore AS, et al. Pregnancy recency and risk of ovarian cancer. Cancer Causes Control. 1999;10:397-402.
23. Riman T, Dickman PW, Nilsson S, et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol. 2002;156:363-373.
24. Whiteman D, Siskind V, Purdie D, et al. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biol Prev. 2003;12: 42-46.
25. Purdie DM, Bain CJ, Siskind V, et al. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104:228-232.
26. Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf). 1998;49:695-707.
27. Schildkraut JM, Cooper GS, Halabi S, et al. Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol. 2001;98:85-90.
28. Titus-Ernstoff L, Perez K, Cramer DW, et al. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer. 2001;84: 714-721.
29. Chiaffarino F, Pelucchi C, Parazzini F, et al. Reproductive and hormonal factors and ovarian cancer. Ann Oncol. 2001;12:337-341.
30. Modugno F, Ness RB, Wheeler JE. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol. 2001;11:568-574.
31. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126:319-325.
32. Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia? Lancet. 1971;2:163.